1. Home
  2. FN vs ASND Comparison

FN vs ASND Comparison

Compare FN & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$534.40

Market Cap

17.1B

Sector

Utilities

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$243.69

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FN
ASND
Founded
1999
2006
Country
Cayman Islands
Denmark
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
15.2B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
FN
ASND
Price
$534.40
$243.69
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$513.43
$281.50
AVG Volume (30 Days)
770.9K
479.0K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
13.21
N/A
EPS
9.22
N/A
Revenue
$3,419,327,000.00
N/A
Revenue This Year
$36.87
$96.35
Revenue Next Year
$17.91
$44.91
P/E Ratio
$49.45
N/A
Revenue Growth
18.60
N/A
52 Week Low
$272.49
$175.19
52 Week High
$748.89
$282.15

Technical Indicators

Market Signals
Indicator
FN
ASND
Relative Strength Index (RSI) 55.81 41.83
Support Level $485.34 $212.03
Resistance Level $631.95 $249.89
Average True Range (ATR) 30.33 7.16
MACD 6.17 -2.64
Stochastic Oscillator 93.53 18.39

Price Performance

Historical Comparison
FN
ASND

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: